Skip to main content

Peer Review reports

From: Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III–IVA esophageal squamous cell carcinoma post-surgery

Original Submission
7 Jun 2023 Submitted Original manuscript
4 Aug 2023 Reviewed Reviewer Report
10 Aug 2023 Reviewed Reviewer Report
17 Sep 2023 Reviewed Reviewer Report - Tomohiko Nishi
8 Oct 2023 Author responded Author comments - Bo Jiang
Resubmission - Version 2
8 Oct 2023 Submitted Manuscript version 2
9 Oct 2023 Author responded Author comments - Bo Jiang
Resubmission - Version 3
9 Oct 2023 Submitted Manuscript version 3
10 Oct 2023 Author responded Author comments - Bo Jiang
Resubmission - Version 4
10 Oct 2023 Submitted Manuscript version 4
Publishing
14 Jan 2024 Editorially accepted
25 Jan 2024 Article published 10.1186/s13019-024-02500-9

You can find further information about peer review here.

Back to article page